Clinical trial
Therapies for Treatment-Resistant Panic Disorder Symptoms
NCT00118417 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00118417 |
|---|---|
| Title | Therapies for Treatment-Resistant Panic Disorder Symptoms |
| Official title | Treatment Refractory Panic Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Panic Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Clonazepam, Sertraline, Cognitive behavioral therapy |
| Enrollment | 46 |
| Start date | Mar 1, 1999 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jul 11, 2005 |
| Last update posted | Jun 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: